Toxicology of Industrial Compounds

58 SIZING UP THE PROBLEM OF EXPOSURE EXTRAPOLATION
REIGNER, B.C., BOIS, F.Y. and TOZER, T.N., 1993, Pentachlorophenol
carcinogenicity: extrapolation of risk from mice to humans, Human Exp.
Toxicol., 12, 215–25.
RITSCHEL, W.A., VACHHARAJANI, N.N., JOHNSON, R.D. and HUSSAIN, A.
S., 1991, Interspecies scaling of the pharmacokinetic parameters of coumarin
among six different mammalian species, Meth. Find Exper. Clin. Pharmacol, 13
(10), 697–702.
SACHER, G.A., 1959, Relation of lifespan to brain weight and body weight in
mammals, in Wolstenholme, G.E.W. and O’Connor, M. (Eds), The Life Span
of Animals, pp. 115–41. Boston, Mass: Little Brown.
SAWADA, Y., HANANO, M., SUGIYAMA, Y. and IGA, T., 1984, Prediction of
the disposition of β-lactam antibiotics in humans from pharmacokinetic
parameters in animals, J. Pharmacokin. Biopharm., 12(3), 241–61.
SAWADA, Y., HANANO, M., SUGIYAMA, Y. and IGA, T., 1985, Prediction of
the disposition of nine weakly acidic and six weakly basic drugs in humans
from pharmacokinetic parameters in rats, J. Pharmacokin. Biopharm., 13(5),
477–92.
SPECTOR, W.S., 1956, Handbook of Biological Data, Philadelphia:
W.B.Saunders.
SWABB, E.A. and BONNER, D.P., 1983, Prediction of aztreonam
pharmacokinetics in humans based on data from animals, J. Pharmacokin.
Biopharm., 11(3), 215–23.
TSUNEKAWA, Y., HASEGAWA, T., NADAI, M., TAKAGI, K. and NABESHIMA,
T., 1992, Interspecies differences and scaling for the pharmacokinetics of
xanthine derivatives, J. Pharm. Pharmacol, 44, 594–9.